Mendel Goldfinger, MD

Mendel Goldfinger, MD is a nationally recognized expert in MDS/AML treatment and has pioneered new drug development in blood cancers and cell therapies. He is the  Director of the Montefiore Hematologic-Malignancy Network and the Clinical Director of Blood Cancers at the Montefiore Einstein Comprehensive Cancer Center. Before joining Montefiore, he was an Assistant Professor of Medicine at Weill Cornell College of Medicine, NY. His practice changing clinical research innovations have been published in Blood, Cancer Discovery and other high impact journals.

He obtained MD degree from SUNY Buffalo School of Medicine, and  was a fellow at Rutgers Robert Wood Johnson Medical School.